Taenia solium Cysticercosis: Present Scenario: A Review

DOI: 10.18805/ag.R-1954    | Article Id: R-1954 | Page : 133-144
Citation :- Taenia solium Cysticercosis: Present Scenario: A Review.Agricultural Reviews.2021.(42):133-144
Acheenta Gohain Barua, Mrinmoyee Sarma, Monoshree Sarma, Kaushik Kakoty, Uttam Rajkhowa, Pranjal Moni Nath acheentagbarua@gmail.com
Address : Deperartment of Veterinary Public Health, College of Veterinary Science, Khanapara-781 022, Assam, India. 
Submitted Date : 5-11-2019
Accepted Date : 9-03-2021

Abstract

Cysticercosis is one of the most important neglected parasitic diseases caused by the larval stage of the tapeworm Taenia solium. It is the most common cause of epilepsy in the areas with improper pig husbandry practices and poor sanitary conditions. In pig the larvae lodges in the muscle and subcutaneous tissue and seldom manifests any clinical sign. In human beings the larval stage resides in the CNS thus leading to the condition Neurocysticercosis. The disease can be diagnosed by using various neuroimaging techniques and immunodiagnostic methods. Available therapeutic options include cysticidal drugs, steroids, anti-epileptic drugs etc. The disease can be controlled by anti-parasitic treatment of the pig and humans residing in endemic areas, vaccinating the pigs, creating awareness and other measures.

Keywords

Cysticercosis Cysticidal drugs Epilepsy Neurocysticercosis Neuroimaging Taenia solium Vaccination

References

  1. Alsina, G.A., Johnson, J.P., McBride, D.Q., Rhoten, P.R., Mehringer, C.M., Stokes, J.K. (2002). Spinal neurocysticercosis. Neurosurgical Focus. 12(6): p. e8. 
  2. Anonymous, (2003). Proceeding of the International Workshop on Taenia solium Cysticercosis/Taeniosis with Special Focus on Eastern and Southern Africa. Arusha, Tanzania. Acta Tropica. 87: 1-2.
  3. Assana, E., Amadou, F., Thys, E., Lightowlers, M.W., Zoli, A.P., Dorny, P., Geerts, S. (2010). Pig-farming systems and orcine cysticercosis in the north of Cameroon. J. Helminthol. 84: 441-446.
  4. Assana, E., Lightowlers, M.L., Zoli, A.P., Geerts, S. (2012). Taenia solium taeniosis/cysticercosis in Africa: Risk factors, epidemiology and prospects for control using vaccination. Veterinary Parasitology. 195: 14-23.
  5. Baranwal, A.K., Singhi, P.D., Khandelwal, N., Singhi, S.C. (1998). Albendazole therapy in children with focal seizures and single small enhancing computerized tomographic lesions: a randomized, placebo-controlled, double blind trial. Pediatric. Infectious Disease Journal. 17(8): 696-700. 
  6. Boa, M.E., Jessen, O.L., Kassuku, A.A., Willingham, A.L. (2001). Prevalence and risk factors for porcine cysticercosis in Southern highlands districts of Chunya and Iringa Rural. In: Genchi, C., Bandi, C., Kramer, L.H., Manfred, M.T., Piettrobelli, M., Lanfranchi, P., Bazzol, S. (Editors). Proceedings of eighteeth 18th International Conference of World Association for Advancement of Veterinary Parasitology: Promoting Advancement, Preserving Tradition. 26 - 30 August 2001, Stresa, Italy pp 7.
  7. Boa, M.E., Makundi, E.A., Kassuku, A.A., Willingham III, A.L., Kyvsgaard, N.C. (2006). Epidemiological survey of swine cysticercosis using ante-mortem and post-mortem examination tests in the southern highlands of Tanzania. Veterinary Parasitology. 139: 249-255.
  8. Bulaya, C., Mwape, K.E., Michelo, C., Sikasunge, C.S., Makungu, C., et al. (2015). Preliminary evaluation of Community-Led total Sanitation for the control of Taenia solium cysticercosis in Katete District of Zambia. Vet. Parasitol. 207: 241-248
  9. Bustos, J.A., Pretell, E..J, Llanos-Zavalaga, F., Gilman, R.H., Del Brutto, O.H., Garcia, H.H. (2006). Efficacy of a 3-day course of albendazole treatment in patients with a single neurocysticercosis cyst. Clinical Neurology and Neurosurgery. 108(2): 193-194. 
  10. Carabin, H., Krecek, R.C., Cowan, L.D., Michael, L., Foyaca-Sibat, H., et al. (2006). Estimation of the cost of Taenia solium cysticercosis in Eastern Cape Province, South Africa. Trop. Med. Int. Health. 11: 906-916.
  11. Cardenas, F., Quiroz, H., Plancarte, A., Meza, A., Dalma, A., Flisser, A. (1992). Taenia solium ocular cysticercosis: findings in 30 cases. Ann Ophthalmol. 24: 25-28. 
  12. Chandra, S., Vashisht, S., Menon, V., Berry, M., Mukherji, S.K. (2000). Optic nerve cysticercosis: imaging findings. AJNR Am. J. Neuroradiol. 21:198-200.
  13. Chiesa, F., Dalmasso, A., Bellio, A., Martinetti, M., Gili, S. and Civera, T. (2010). Development of a Biomolecular Assay for Postmortem Diagnosis of Taenia saginata Cysticercosis. Food borne Pathogens and Disease. 7(10): 1171-1175.
  14. Chowdary, G.V.S., Murthy, J.M.K., Vijay, S. (2004). Prevalence of seizure disorders associated with neurocysticercosis; a community based study comprehensive rural epilepsy study South India. In: The Asian and ocean congress of neurology, Singapore.
  15. Coyle, C.M., Mahanty, S., Zunt, J.R., Wallin, M.T., Cantey, P.T., White, A.C., et al. (2012). Neurocysticercosis: neglected but not forgotten. PLoS Negl Trop Dis. 6:
  16. Del Brutto OH, Sotelo J, Román G. (1998). Neurocysticercosis: A Clinical Handbook. Lisse, The Netherlands: Swets and Zeitlinger.
  17. Del Brutto, O.H. (1997). Albendazole therapy for subarachnoid cysticerci: clinical and neuroimaging analysis of 17 patients. Journal of Neurology Neurosurgery and Psychiatry. 62(6): 659-661. 
  18. Del Brutto, O.H. (2008) Stroke and vasculitis in patients with cysticercosis. In: Caplan LR, editor. Uncommon Causes of Stroke. New York, NY, USA: Cambridge University Press, pp. 53-58.
  19. Del Brutto, O.H. and Garcia, H.H. (2012). Neurocysticercosis in nonendemic countries:time for a reappraisal. Neuroepidemiology. 39: 145-146.
  20. Del Brutto, O.H. (1994). Prognostic factors for seizure recurrence after withdrawal of antiepileptic drugs in patients with neurocysticercosis. Neurology. 44(9): 1706-1709. 
  21. Del Brutto, O.H., Campos, X., Sánchez, J., Mosquera, A. (1999). Single-day praziquantel versus 1-week albendazole for neurocysticercosis. Neurology. 52(5): 1079-1081. 
  22. Del Brutto, O.H., Castillo, P.R., Mena, I.X., Freire, A.X. (1997). Neurocysticercosis among patients with cerebral gliomas. Archives of Neurology. 54(9): 1125-1128. 
  23. Del Brutto, O.H., Guevara, J., Sotelo, J. (1988). Intrasellar cysticercosis. Journal of Neurosurgery. 69(1): 58-60. 
  24. Del Brutto, O.H., Rajshekhar, V., White, A.C., et al. (2001) Proposed diagnostic criteria for neurocysticercosis. Neurology. 57 (2): 177-183.
  25. Del Brutto, O.H., Santibañez, R., Idrovo, L., et al. (2005). Epilepsy and neurocysticercosis in Atahualpa: a door-to-door survey in rural coastal Ecuador. Epilepsia. 46(4): 583-587. 
  26. Del Brutto, O.H., Santibáñez, R., Noboa, C.A., Aguirre, R., Diaz, E., Alarcon, T.A. (1992). Epilepsy due to neurocysticercosis: analysis of 203 patients. Neurolog. 42(2): 389-392.
  27. Del Brutto and Oscar, H., (2012). Neurocysticercosis: A review. The Scientific World Journal. doi. Org/10.1100/2012/159821.
  28. Del Brutto, O.H., Dolezal, M., Castillo, P.R., García, H.H. (2000). Neurocysticercosis and oncogenesis. Archives of Medical Research. 31(2): 151-155. 
  29. Dixon, H.B.F. and Smithers, D.W. (1934). Epilepsy in cysticercosis (Taenia solium): a study of seventy-one cases. QJM. 3: 603-16. 
  30. Do, Amaral, L.L.F., Ferreira, R.M., Da Rocha, A.J., Fortes Ferreira, N.P.D. (2005). Neurocysticercosis: evaluation with advanced magnetic resonance techniques and atypical forms. Topics in Magnetic Resonance Imaging. 16(2): 127-144. 
  31. Dorny, P., Phiri, I.K., Vercruysse, Gabriel, S., Willingham III, A.L., Brandt, J., Victor, B., Speybroeck, N. and Berkvens, D. (2004). A Bayesian approach for estimating values for prevalence and diagnostic test characteristics of porcine cysticercosis, Int. J. Parasitol. 34: 569-576.
  32. Escobar, A. and Weidenheim, K.M. (2002). The pathology of neurocysticercosis. In: Singh G, Prabhakar S, editors. Taenia Solium Cysticercosis. From Basic to Clinical Science. Oxon, UK: CAB International. pp. 289-305.
  33. Escobedo, F., Penagos, P., Rodriguez, J., Sotelo, J. (1987). Albendazole therapy for neurocysticercosis. Archives of Internal Medicine. 147(4): 738-741. 
  34. Fleury, A., Carrillo-Mezo, R.., Flisser, A., Sciutto, E., Corona, T. (2011). Subarachnoid basal neurocysticercosis: a focus on the most severe form of the disease. Expert Review of Anti-Infective Therapy. 9(1): 123-133
  35. Flisser, A., Correa, D., Evans, C.A.W. (2002). Taenia Solium Cysticercosis. From Basic to Clinical Science. Oxon, UK: CAB International.
  36. Forlenza, O., Vieira, A.H., Nobrea, J.P.S., et al. (1997). Psychiatric manifestations in neurocysticercosis: a study of 38 patients from a neurologic clinics in Brazil. Journal of Neurology. Neurosurgery and Psychiatry. 62: 612-616. 
  37. García, H.H. and Del Brutto, O.H. (1999). Heavy nonencephalitic cerebral cysticercosis in tapeworm carriers. The Cysticercosis Working Group in Perú. Neurology. 53(7): 1582-1584. 
  38. Garcia, H.H., Del Brutto, O.H., Nash, T.E., White, A.C., Tsang, V.C.W., Gilman, R.H. (2005). New concepts in the diagnosis and management of neurocysticercosis (Taenia solium). American Journal of Tropical Medicine and Hygiene. 72(1): 3-9.
  39. García, H.H., Evans, C.A.W., Nash, T.E., et al. (2002). Current consensus guidelines for treatment of neurocysticercosis. Clinical Microbiology Reviews. 15(4): 747-756. 
  40. Garcia, H.H., Gilman, R.H., Horton, J., et al. (1997). Albendazole therapy for neurocysticercosis: a prospective double-blind trial comparing 7 versus 14 days of treatment. Neurology. 48(5): 1421-1427. 
  41. Garcia, H.H., Pretell, E.J., Gilman, R.H., et al. (2004). A trial of antiparasitic treatment to reduce the rate of seizures due to cerebral cysticercosis. New England Journal of Medicine. 350(3): 249-258. 
  42. Gauci, C. and Lightowlers, M.W. (2003). Molecular cloning of genes encoding oncosphere proteins reveals conservation of modular protein structure in cestode antigens. Mol. Biochem Parasitol. 127: 193-8. 
  43. Gauci, C.G. and Lightowlers, M.W. (2001). Alternative splicing and sequence diversity of transcripts from the oncosphere stage of Taenia solium with homology to the 45W antigen of Taenia ovis. Mol Biochem Parasitol. 112: 173-81. 
  44. Gauci, C.G., Flisse,r A., Lightowlers, M.W. (1998). A Taenia solium oncosphere protein homologous to host-protective Taenia ovis and Taenia saginata 18 kDa antigens. Int. J. Parasitol. 28: 757-60. 
  45. Gilman, R.H., Del Brutto, O.H., García, H.H., Martínez, M. (2000). Prevalence of taeniosis among patients with neurocysticercosis is related to severity of infection. Neurology. 55(7): 1062. 
  46. Gogia, S., Talukdar, B., Choudhury, V., Singh Arora, B. (2003). Neurocysticercosis in children: clinical findings and response to albendazole therapy in a randomized, double-blind, placebo-controlled trial in newly diagnosed cases. Transactions of the Royal Society of Tropical Medicine and Hygiene. 97(4): 416-421. 
  47. Gomes, A.B., Soares, K.A., Bueno, F.C., Espindola, N.M., Tha, A.H., Maia, A.A.M., Peralta, R II, S. and Vaz, A.J. (2007). Comparative evaluation of different immunoassays for the detection of Taenia solium cysticercosis in swine with low parasite burden. Memrias do Instituto Oswaldo Cruz. 102(6): 725-731.
  48. Góngora-Rivera, F., Soto-Hernández, J.L., González Esquivel, D., et al. (2006). Albendazole trial at 15 or 30 mg/kg/day for subarachnoid and intraventricular cysticercosis. Neurology. 66(3): 436-438. 
  49. Gonzalez, A.E., Garcia, H.H., Gilman, R.H., et al. (1996). Effective, single-dose treatment or porcine cysticercosis with oxfendazole. Am. J. Trop. Med. Hyg. 54: 391-94.
  50. Gonzalez, A.E., Falcon, N., Gavidia, C., et al. (1997). Treatment of porcine cysticercosis with oxfendazole: a dose-response trial. Vet. Rec. 141: 420-22. 
  51. Gonzalez, A.E., Falcon, N., Gavidia, C., et al. (1998). Time-response curve of oxfendazole in the treatment of swine cysticercosis. Am. J. Trop. Med. Hyg. 59: 832-36. 
  52. Goussanou, J.S.E., Kpodekon, M.T., Youssao, A.K.I., Farougou, S., Korsak, N. (2014). Epidemiological tools for effective surveillance of porcine cysticercosis in Africa, Veterinary World. 7(3): 125-134.
  53. Juyal, P.D., Sharma, R., Singh, N.K., Singh, G. (2008). Epidemiology and control strategies against cysticercosis (due to Taenia solium) with special reference to swine and human in Asia. Journal of Veterinary and Animal Science. 1: 1-10.
  54. Kalra, V., Dua, T., Kumar, V. (2003). Efficacy of albendazole and short-course dexamethasone treatment in children with 1 or 2 ring-enhancing lesions of neurocysticercosis: a randomized controlled trial. Journal of Pediatrics. 143(1): 111-114. 
  55. Keilbach, N.M., De Aluja, A.S., Sarti-Gutierrez, E. (1989). A programme to control taeniasis-cysticercosis (T. solium): experiences in a Mexican village. Acta Leidensia. 57(2): 181-189. 
  56. Khurana, S., Aggarwal, A., Malla, N. (2006). Prevalence of anti-cysticercus antibodies in slum, rural and urban populations in and around Union territory, Chandigarh. Indian J. Pathol. Micro-biol. 49: 51-53.
  57. Lightowlers, M.W. (2010). Eradication of Taenia solium cysticercosis: a role for vaccination of pigs. Int. J. Parasitol. 40: 1183-92.
  58. Lokhande, A.T., Tambe, D.R., Kamble, S.S. and Vidhate, P.M. (2016). Molecular characterization of cysticercosis in pigs of Maharastra. International journal of Tropical Agriculture. 34(6): 1447-1454.
  59. Madiubba, S., Vishwanath, K., Reddy, G., et al. (2007). Chaning trends in ocular cysticercosis over two decades: an analysis of 118 surgically excised cysts. Indian Journal of Medical Microbiology. 25: 214-219. 
  60. Madrazo, I., Garcia Renteria, J.A., Sandova, l.M., Lopez Vega, F.J. (1983). Intraventricular cysticercosis. Neurosurgery. 12 (2): 148-152. 
  61. Mahanty, S. and Garcia, H.H. (2010). (Cysticercosis and neurocysticercosis as pathogens affecting the nervous system. Progress in Neurobiology. 91(2): 172-184. 
  62. Medina, M.T., Duron, R.M., Martinez, L. (2005). Prevalence, incidence and etioloy of epilepsies in rural Honduras: the Salama study. Epilepsia. 46: 124-131. 
  63. Michault, A., Duval, G., Bertil, G., Folio, G. (1990). Sero-epidemiological study ofcysticercosis in Reunion Island. Bull. Soc. Pathol. Exot. 83: 82-92.
  64. Michault, A., Leroy, D., Coubes, P., Laporte, J.P., Bertil, G., Mignard, C. (1989). Immunological diagnosis in the cerebrospinal fluid and serum in patients withevolutive cerebral cysticercosis by ELISA. Trans. Zool. Soc. London. 37: 249-253.
  65. Michelet, L., Carod, J.-F., Rakotondrazaka, M., Ma, L., Gay, F., Dauga, C. (2010). The pigtapeworm Taenia solium, the cause of cysticercosis: biogeographic (temporaland spacial) origins in Madagascar. Mol. Phylogenet. Evol. 55: 744-750.
  66. Montano, S.M., Villaran, M.V., Ylquimiche, L., et al. (2005). Neuro- -cysticercosis: association between seizures, serology and brain CT in rural Peru. Neurology. 65(2): 229-234.
  67. Moyano, L.M., Saito, M., Montano, S.M., Gonzalvez, G., Olaya, S., Ayvar, V., González, I., Larrauri, L., Tsang, V.C., Llanos, F., Rodríguez, S., Gonzalez, A.E., Gilman, R.H., Garcia, H.H. (2014). Neurocysticercosis as a cause of epilepsy and seizures in two community-based studies in a cysticercosis-endemic region in Peru. PLoS Negl. Trop. Dis. 8: e2692.
  68. Ndimubanzi, P.C., Carabin, H., Budke, C.M., Nguyen, H., Qian. Y.J., Rainwater, E., et al. (2010). A systematic review of the frequency of neurocyticercosis with a focus on people with epilepsy. PLoS Negl Trop Dis. 4.
  69. Newell, E., Vyungimana, F., Geerts, S., Van Kerckhoven, I., Tsang, V.C. and Engels, D. (1997). Prevalence of cysticercosis in epileptics and members of their families in Burundi. Transactions of the Royal Society of Tropical Medicine and Hygiene. 91(4): 389–391.
  70. Ngowi, H.A., Kassuku, A.A., Maedab, G.E.M., Boa, M.E., Carabin, H., Will-ingham III, A.L. (2004). Risk factors for the prevalence of porcinecysticercosis in Mbulu District, Tanzania. Vet. Parasitol. 120: 275-283.
  71. Ngowi, H.A., Phiri, I.K., Matenga, E., Afonso, S., Boa, M.E., Mutaratirwa, S., Githigia, S., Saimon, S.C., Maingi, N., Lubega, G.W., Kassuku, A., Michael, I., Siziya, S., Krecek, R.C., Noormahomed, E.V., Nsengiyumva, M., Andriantsimahavandy, A., Dorny, P., Johansen, M.., Willingham III A.L. (2004). Taenia solium cysticercosis in Eastern and Southern Africa: An emerging problem in agriculture and public health. Journal of Tropical Medicine and Public Health. 35: 266-270.
  72. Nguekam, J.P., Zoli, A.P., Zogo, P.O., Kamga, A.C., Speybroeck, N., Dorny, P., Brandt, J.,Losson, B., Geerts, S. (2003). A seroepidemiological study of human cysticercosisin West Cameroon. Trop. Med. Int. Health. 8: 144-149.
  73. Nieto, D. (1982). Historical notes on cysticercosis. In: Flisser, A., Willms, K., Laclete, J.P., Larralde, C., Ridaura, C., Beltrán, F., editors. Cysticercosis: Present State of Knowledge and Perspectives. New York, NY, USA: Academic Press.1-7.
  74. Ogunremi, O. and Benjamin, J. (2010). Development and field evaluation of a new serological test for Taenia saginata cysticercosis. Vet. Parasitol. 169: 93-101.
  75. Pawlowski, Z.S. (2006). Role of chemotherapy of taeniasis in prevention of neurocysticercosis. Parasitology International. 55: S105-S109. 
  76. Phiri, I.K., Ngowi, H., Alfonso, S., Matenga, E., Boa, M.E., Mukaratirwa, S., Githigia, S., Saimo, M., Sikasunge, C., Maingi, N., Lubega, G., Kassuku, A.A., Michael, L., Siziya, S., Krecek, R.C., Noormahomed, E., Vilhelna, M., Dony, P. and Willigham, III A.L. (2003). The prevalence of Taenia solium cysticercosis in Eastern and Southern Africa as a serious agricultural problem and public health risk. Acta Tropica. 87: 13-23.
  77. Pittella, J.E.H. (1997). Neurocysticercosis. Brain Pathology. 7(1): 681-693. 
  78. Pouedet, M.S., Zoli, A.P., Nguekam, J., Vondou, L., Assana, E., Speybroeck, N.,Berkvens, D., Dorny, P., Brandt, J., Geerts, S. (2002). Epidemiological sur-vey of swine cysticercosis in two rural communities of West-Cameron. Vet. Parasitol. 106: 45-54.
  79. Praet, N., Kanobana, K., Kabwe, C., Maketa, V., Lukanu, P., Lutumba, P., Polman, K., Matondo, P., Speybroeck, N., Dorny, P., Sumbu, J. (2010). Taenia solium cysticercosis in the Democratic Republic of Congo: how does pork trade affect the transmission of the parasite. PLoS Negl. Trop Dis. 4(9): 547–556.
  80. Pretell, E.J., García, H.H., Gilman, R.H., Saavedra, H., Martinez, M. (2001). Failure of one-day praziquantel treatment in patients with multiple neurocysticercosis lesions. Clinical Neurology and Neurosurgery. 103(3): 175-177. 
  81. Proaño, J.V., Madrazo, I., Avelar, F., López-Félix, B., Díaz, G., Grijalva, I. (2001). Medical treatment for neurocysticercosis characterized by giant subarachnoid cysts. New England Journal of Medicine. 345(12): 879-885. 
  82. Rajshekhar, V. (2010). Surgical management of neurocysticercosis. International Journal of Surgery. 8(2): 100-104.
  83. Ramahefarisoa, R.M., Rakotondrazaka, M., Jambou, R. and Carod, J.F. (2010). Comparison of ELISA and PCR assays for the diagnosis of porcine cysticercosis in Madagascar. Vet. Parasitology. 173: 336-339.
  84. Rangel, R., Torres, B., Del Bruto, O., Sotelo J. (1987). Cysticercotic encephalitis: a severe form in young females. American Journal of Tropical Medicine and Hygiene. 36(2): 387-392. 
  85. Roman, G., Sotelo, J., Del Brutto, O., Flisser, A., Dumas, M., Wadia, N., Botero, D., Cruz, M., Garcia, H., De Bittencourt, P. (2000). A proposal to declare neurocysticercosis an international reportable disease. Bulletin of the World Health Organization. 78(3): 399-406. 
  86. Rottbeck, R., Nshimiyimana, J.F., Tugirimana, P., Düll, U.E., Sattler, J., Hategekimana, J.C., Hitayezu, J., Bruckmaier, I., Borchert, M., Gahutu, J.B., Dieckmann, S., Harms, G., Mockenhaupt, F.P., Ignatius, R.(2013). High prevalence of cysticercosis in people with epilepsy in southern Rwanda. PLoS Negl. Trop. Dis. 7: e2558.
  87. Sako, Y., Nakao, M., Ikejima, T., Piao, X.Z.,, Nakaya K., Ito, A. (2000). Molecular characterization and diagnostic value of Taenia solium low-molecular-weight antigen genes. J. Clin. Microbiol. 38(12): 4439-44.
  88. Salinas, R., Counsell, C., Prasad, K., Gelband, H., Garner, P. (1999). Treating neurocysticercosis medically: a systematic review of randomized, controlled trials. Tropical Medicine and International Health. 4(11): 713-718. 
  89. Samuel, M., Purity, N., Lucy, W.K.(2018). Risk factors associated wuth the occurrence of porcine cysticercosis in Kianbu, Kenya. International journal of Innovative Research and Development. 7.
  90. Sarti, E. and Rajshekhar, V. (2003). Measures for prevention and control ofTaenia solium taeniosis and cysticercosis Sarti, E., Schantz, P.M., Plancarte, A., Wilson, M., Gutierrez, I.O., Lopez, A.S., Roberts, J., Flisser, A. (1992). Prevalence and risk factors for Taenia solium taeniasis and cysticercosis in humans and pigs in a village in Morelos, Mexico. The American Journal of Tropical Medicine and Hygiene. 46 (6): 677-685.
  91. Sciutto, E., Fragoso, G., de Aluja, A.S., Hernández, M., Rosas, G., Larralde, C. (2008). Vaccines against cysticercosis. Curr. Top. Med. Chem. 8: 415-23. 
  92. Sciutto, E., Martinez, J.J., Villalobos, N.M., Hernandez, M., Jose, M.V., Bel-tran, C., Rodarte, F., Flores, I., Bobadilla, J.R., Fragoso, G., Parkhouse,M.E., Harrison, L.J., de Aluja, A.S. (1998). Limitations of current diag-nostic procedures for the diagnosis of Taenia solium cysticercosis inrural pigs. Vet. Parasitol. 79: 299-313.
  93. Secka, A., Marcotty, T., De Deken, R., Van Marck, E., Geerts, S. (2010). Porcinecysticercosis and risk factors in the Gambia and Senegal. J. Parasitol. Res.
  94. Sikasunge, C.S., Phiri, I.K., Phiri, A.M., Dorny, P., Siziya, S., WillinghamIII, A.L. (2007). Risk factors associated with porcine cysticercosis inselected districts of Eastern and Southern provinces of Zambia. Vet. Parasitol. 143: 59-66.
  95. Sikasunge, C.S., Phiri, I.K., Phiri, A.M., Siziya, S., Dorny, P., Willingham 3rd, A.L. (2008). Prevalence of Taenia solium porcine cysticercosis inthe Eastern, Southern and Western provinces of Zambia. Vet. J. 176: 240-244.
  96. Singh, G., Rajshekhar, V., Murthy, J.M.K., et al. (2010). A diagnostic and therapeutic scheme for a solitary cysticercus granuloma. Neurology. 75(24): 2236-2245. 
  97. Singhi, S. and Singhi, P. (1997). Clinical profile and etiology of Partial seizures in North Indian infants and children. J. Epilepsy. 10: 32 36.
  98. Sotelo, J. and Diaz-Olavarrieta, C.(2010). Neurocysticercosis: changes after 25 years of medical therapy. Archives of Medical Research. 41(1): 62-63. 
  99. Sotelo, J., Del Brutto, OH., Penagos, P., et al. (1990). Comparison of therapeutic regimen of anticysticercal drugs for parenchymal brain cysticercosis. Journal of Neurology. 237(2): 69-72. 
  100. Sotelo, J., Escobedo, F., Rodriguez-Carbajal, J., et al. (1984). Therapy of parenchymal brain cysticercosis with praziquantel. New England Journal of Medicine. 310(16): 1001-1007. 
  101. Sreedevi, C., Hafeez, M., Kumar, P.A., Rayulu, V.C., Subramanyam, K.V. and Sudhakar, K. (2012). PCR test for detecting Taenia solium cysticercosis in pig carcasses. Trop Anim Health Prod. 44(1): 95-9
  102. Swastika, K., Dharmawan, N.S, S.,ardita,I.K., Kepeng, I.N., Wandra, T., Sako, Y., Okamoto, M., Yanagida, T., Sasaki, M., Giraudoux, P., Nakao, M., Yoshida, T., Diarthini L.P., Sudramaja, I.M., Purba, I.E., Budke, C.M., Ito, A. (2016). Acta Tropica. 163: 46-53
  103. Takayanagui, O.M. and Jardim, E. (1992). Therapy for neurocysticercosis: comparison between albendazole and praziquantel. Archives of Neurology. 49(3): 290-294. 
  104. Torgerson, P.R., Macpherson, C.N. (2011). The socioeconomic burden of parasiticzoonoses: global trends. Vet. Parasitol. 182: 79-95.
  105. Tsang, V.C.W., Brand, J.A., Boyer, A.E. (1989). An enzyme-linked immunoelectrotransfer blot assay and glycoprotein antigens for diagnosing human cysticercosis (Taenia solium) Journal of Infectious Diseases. 159(1): 50-59. 
  106. Wadia, N., Desai, S., Bhatt, M. (1988). Disseminated cysticercosis. New observations, including CT scan findings and experience with treatment by praziquantel. Brain. 111(3): 597-614. 
  107. WHO, (2013). Sustaining the drive to overcome the global impact of neglectedtropical diseases: second WHO report on neglected diseases. Geneva, World Health Organization., in: Crompton, D.W. Ed. World Health Organization. p.153.
  108. WHO, (2014). Neglected Tropical Diseases: Cysticercosis-Taeniasis. Neglected tropical diseases.
  109. WHO, (2017). First ever licensed vaccine and anthelmentic against the major cause of epilepsy in the developing world. Neglected tropical diseases.
  110. WHO. (2015). WHO Estimates of the Global Burden of Food borne Diseases Geneva, Switzerland: World Health Organization. 
  111. WHO/FAO/OIE. (2005). Guidelines for the Surveillance, Prevention and Control of Taeniosis/Cysticercosis. Murrell, K..D. Ed Paris : World Organisation for Animal Health. 193 p.
  112. Willingham III, A.L., Wu, H.W., Conlan, J., Satrija, F. (2010). Combating Taenia solium cysticercosis in Southeast Asia an opportunity for improving human health and livestock production. Advanced Parasitology. 72: 235-266.
  113. Willms, K. (2008). Morphology and biochemistry of the pork tapeworm, Taenia solium. Current Topics in Medicinal Chemistry. 8(5): 375-382.
  114. World Health Organization. (2003). Fifty-Sixth World Health Assembly Control of Neurocysticercosis.
  115. Yoder, D.R., Ebel, E.D., Hancock, D.D., Combs, B.A. (1994). Epidemiologic findings from an outbreak of cysticercosis in feedlot cattle. J. Am. Vet. Med. Assoc. 205: 45-50
  116. Zoli, A., Shey-Njila, O, Assana, E., Nguekam, J.P, Dorney, P., Brandt, J., Geerts. 2003 Regional status, epidemiology and impact of Taenia solium Cysticercosis in Western and Central Africa. Acta tropica. 87: 35-42.

Global Footprints